Intelligence Platform
Patents
Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10857139
Substituted diazaspiroalkanes as androgen receptor modulators
granted patentUS 10857140
K-Ras modulators
granted patentUS 10851367
Tissue-specific genome engineering using CRISPR-Cas9
granted patentUS 10851463
Membrane template synthesis of microtube engines
granted patentUS 10849965
H3.3 CTL peptides and uses thereof
granted patentUS 10849910
Use of H3K9me3 modulation for enhancing cognitive function
granted patentUS 10849988
Hydrogel for engineered immune response to D-chirality peptides
granted patentUS 10842743
Modified hyaluronic acid hydrogels and proteins for the time-controlled release of biologi
granted patentUS 10842908
Polyphosphate-functionalized inorganic nanoparticles as hemostatic compositions and method
granted patentUS 10844052
LLS compounds for treatment of cancer
granted patentUS 10844102
Peptides, compositions, and methods for stimulating subcutaneous adipogenesis
granted patentUS 10836808
Binding-triggered transcriptional switches and methods of use thereof
granted patentUS 10837001
Cardiomyocyte maturation platform
granted patentUS 10836720
Inhibitors of integrin alpha 5 beta 1 and methods of use
granted patentUS 10835513
Methods and treatments for the learning and memory deficits associated with Noonan syndrom
granted patentUS 10829536
Methods of promoting CNS neuronal repair by inhibiting LRP-1
granted patentUS 10828255
Lipid bilayer coated mesoporous silica nanoparticles with a high loading capacity for one
granted patentUS 10828289
Hair follicle stem cell activation and hair growth
granted patentUS 10828265
Formulations of propranolol and analogs as an amorphous melt or ionic liquid for transderm
granted patentUS 10828414
Magnetic filtration devices and methods related thereto
granted patentUS 10822585
Compositions and methods for treating retinal diseases
granted patentUS 10822427
Anti-CSPG4 fusions with interferon for the treatment of malignancy
granted patentUS 10822340
Substituted imidazolopyrazine compounds and methods of using same
granted patentUS 10821117
Estrogen therapy for brain gray matter atrophy and associated disability
granted